Gentamicin Sulfate
15 NDCs across 7 manufacturers|15 Generic,0 Brand
Gentamicin Sulfate is used to treat infectious bone diseases, central nervous system infections, endocarditis, escherichia coli infections, bacterial eye infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $13 million on Gentamicin Sulfate across 404,000 claims for 259,000 beneficiaries.
Gentamicin Sulfate is available as 15 NDCs from 7 manufacturers (15 generic, 0 brand), with NADAC prices from $0.77 to $0.94 per GM — a 22% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
15
15G / 0B
Manufacturers
7
competing in market
Price Spread
$0.77 – $0.94
per GM, 8 of 15 NDCs
7d Activity
avg +1.8% WoW · of 15 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Padagis Israel Pharmaceuticals Ltd manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Aminoglycoside Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing GENTAMICIN SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GENTAMICIN 80 MG/2 ML VIAL | $1.3026 per ML | -4.04% |
GENTAMICIN 80 MG/2 ML VIAL | $1.3026 per ML | -4.04% |
GENTAMICIN 80 MG/2 ML VIAL | $1.3026 per ML | -4.04% |
GENTAMICIN 0.1% OINTMENT | $0.9407 per GM | +3.49% |
GENTAMICIN 0.1% OINTMENT | $0.9407 per GM | +3.49% |
GENTAMICIN 40 MG/ML VIAL | $0.9335 per ML | — |
GENTAMICIN 0.3% EYE DROP | $0.9256 per ML | — |
GENTAMICIN 0.1% CREAM | $0.8871 per GM | +1.07% |
GENTAMICIN 0.1% CREAM | $0.8871 per GM | +1.07% |
GENTAMICIN 0.1% CREAM | $0.8843 per GM | +9.36% |
GENTAMICIN 0.1% CREAM | $0.8843 per GM | +9.36% |
GENTAMICIN 0.3% EYE DROP | $0.7900 per ML | +6.04% |
GENTAMICIN 0.3% EYE DROP | $0.7900 per ML | +6.04% |
GENTAMICIN 0.1% OINTMENT | $0.7705 per GM | -2.25% |
GENTAMICIN 0.1% OINTMENT | $0.7705 per GM | -2.25% |
Frequently Asked Questions
What is Gentamicin Sulfate used to treat?
Gentamicin Sulfate is used to treat infectious bone diseases, central nervous system infections, endocarditis, escherichia coli infections, bacterial eye infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.
When did Gentamicin Sulfate become available as a generic?
FDA approved the first generic Gentamicin Sulfate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Gentamicin Sulfate?
In 2024, Medicare Part D spent $13 million on Gentamicin Sulfate across 404,000 claims for 259,000 beneficiaries.
How many Gentamicin Sulfate products are on the market?
The Gentamicin Sulfate drug market contains 15 NDCs from 7 manufacturers — 15 generic and 0 brand products.
What is the price range for Gentamicin Sulfate?
NADAC reference prices for Gentamicin Sulfate range from $0.7705 to $0.9407 per GM — a 22% difference between cheapest and most expensive. 7 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Gentamicin Sulfate?
7 manufacturers list Gentamicin Sulfate in NADAC. Ranked by number of NDCs, the largest are Padagis Israel Pharmaceuticals Ltd (4), Cosette Pharmaceuticals, Inc. (4), Fresenius Kabi USA, LLC (3), Hospira Inc. (1), Pacific Pharma, Inc. (1).
How has the price of Gentamicin Sulfate changed recently?
Over the past 7 days, 8 Gentamicin Sulfate NDCs rose and 5 fell, with a market-wide average change of +1.8%.